FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/12/060886 [Registered on: 28/12/2023] Trial Registered Prospectively
Last Modified On: 21/12/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A study for the comperison of pain-free duration after administration of inj.butorphenal vs inj.fentanyl with inj.levobupivacaine epidurally in patients undergoing vaginal hysterectomy  
Scientific Title of Study   A comparision of epidural butorphanol and fentanyl as an adjuvant with 0.5%levobupivacaine for postoperative analgesia in patients undergoing vaginal hysterectomy 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DrARVIND KHARE 
Designation  Senior professor 
Affiliation  Jawahar lal neharu medical college  
Address  department of anaesthesiology, new OT, 1st floor JLN medical hospital kalabagh, Ajmer Rajastan

Ajmer
RAJASTHAN
305001
India 
Phone  9414306114  
Fax    
Email  arvindkhare68@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrARVIND KHARE 
Designation  Senior professor 
Affiliation  Jawahar lal neharu medical college  
Address  Department of anaesthesiology, new OT, 1st floor JLN hospital kalabagh, Ajmer Rajastan


RAJASTHAN
305001
India 
Phone  9414306114  
Fax    
Email  arvindkhare68@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DrARVIND KHARE 
Designation  Senior professor 
Affiliation  Jawahar lal neharu medical college  
Address  Department of anaesthesiology new OT 1st floor JLN hospital kalabagh, Ajmer Rajastan


RAJASTHAN
305001
India 
Phone  9414306114  
Fax    
Email  arvindkhare68@gmail.com  
 
Source of Monetary or Material Support  
Department of anaesthesiology JLN medical college and hospitals, Kalabhag road, Ajmer Rajastan 305001  
 
Primary Sponsor  
Name  JLN medical college  
Address  kalabagh Ajmer rajastan 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrKavya L  JLN medical college and hospital  department of anaesthesiology, new OT 1st floor JLN hospital kalabagh
Ajmer
RAJASTHAN 
9916482226

lkavya11@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethical committee Jawaharlal nehru medical college and hospitals ajmer  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N819||Female genital prolapse, unspecified, (2) ICD-10 Condition: 1||Obstetrics,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  inj.butorphenal 2mg inj.Fentanyl 50 mcg   with due approval from institutional ethical committee , a prospective randomized double blinded study has been planned on 80 adult female patients who will be undergoing vaginal hysterectomy under epidural anaesthesia. participants will be allotted into group LB receiving inj.butorphenal and group LF receiving inj.fentanyl as an adjuvant with local anaesthetic in above mentioned dose as single injection. will be compared for duration of analgesia, monitored till patient complains of pain in postoperative period. a written informed consent will be taken from participants prior the procedure 
Intervention  inj.Butorphenal 2mg inj.Fentanyl 50 mcg   with due approval from institutional ethical committee, a prospective randomized double blinded study has been planned on adult female patients who will be undergoing vaginal hysterectomy under epidural anaesthesia. participants will be allocated in to Group LB receiving Inj. butorphanal and group LF receiving inj.fentanyl as an adjuvant with inj.levobupvacaine 0.5% epidurally at dose as mentioned above as single time administration. will be compared for duration of analgesia, monitored till they complain of pain during postoperative period. a written informed consent will be taken from all the participants prior the procedure.  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  70.00 Year(s)
Gender  Female 
Details  ASA 1 and 2
female undergoing vaginal hysterectomy
 
 
ExclusionCriteria 
Details  ASA >2
comorbidities
pregnant patients
breastfeeding
local infection

 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of analgesia  assessment of visual analogue score for pain in postoperative period at immediately after shifting post operative unit,after 1hr,2hr,3hr,4hr, 6hr,8hr,10hr 
 
Secondary Outcome  
Outcome  TimePoints 
onset & duration of sensory block
onset duration of motor block 
assessment of sensory block using pinprick sensation assessed
assessment of motor block by modified bromage scor at baseline,5minutes,10minutes,15minutes,30minutes,1hr,2hr,3hr,4hr,6hr,8hr & postoperative period hourly interwal 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   04/01/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This will be a double blinded randomized study conducted to evaluate inj. Butorphenal 2mg and inj. fentanyl 50 mcg as an adjuvant with inj.levobupivacaine 0.5% 15ml epidurally in  patients who are between 30 to 70yr old, ASA grade 1 or 2 with excemption of all exclusion criteria mentioned above and  undergoing vaginal hysterectomy under epidural analgesia with primary objective of comparing the  duration of analgesia. seconadry objectives being onset and duration of sensory block, onset and duration of motor block, cardiovascular effects, side effects . participants will be allocated in to 2 groups  each with 40 sample size . Group LB receiving inj.butorphenal group LF receiving inj.fentanyl as an adjuvant with local anaesthetic epidurally in above mentioned dosagey. pre anaesthetic evaluation will be done previous day , necessary premedication will be given , informed written consent will be taken prior  to surgery. all emergency drugs and equipments will be kept ready in prior. under all aseptic precautions respective drugs will be given epidurally to respective group of patient. patient will be monitored intraoperative and postoperatively. all the parameters will be recorded at pre described interval  and documented. data will be analyses statistically using standard qualitative and quantitative tests. continuous variables will be analyzed using student paired test and chategorical variables will be analyzed using chi-square test. P value of less than  0.05  will be considered significant. 
Close